Delivery Order SPE2DB22D1103-SPE2DB25FTAH4

Award Date 10/10/24
Potential Completion Date 10/11/24
Potential Value $4.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for $2,591.28. The order is for 4,565,250,079 units of teriparatide 600 mcg/2.4 ml pen with a 2.4 ml capacity. The order has a firm fixed price and a completion date of July 26, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical to provide a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Teriparatide 600 mcg/2.4 mL pens. The contract has a ceiling value of $2,100.62 and a period of performance through September 5, 2024. It is a firm fixed-price contract, with no set-aside designation. This delivery order is likely part of a larger Indefinite Delivery Contract (IDC) vehicle between AmerisourceBergen and the DLA Troop...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,567,943,582 units of the medication teriparatide 560mcg/2.24ml pen, with a ceiling value of $11,646.66 and a performance period through April 17, 2025. The contract is not set aside and was awarded on April 16, 2025. Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery Contract...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,289.24, is for the delivery of 4,567,969,223 units of the medication Teriparatide 560MCG/2.24ML Pen 2.24ML. The contract has an ultimate completion date of April 21, 2025 and was awarded on April 18, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC)...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TERIPARATIDE 600 MCG/2.4ML PEN 2.4ML, a specialty medication, with a ceiling value of $1,403.14 and a performance period ending on January 17, 2025. The contract is a firm fixed-price delivery order and does not have a set-aside designation, indicating open competition. Amerisourcebergen...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of TERIPARATIDE 560MCG/2.24ML PEN 2.24ML. The contract is a firm fixed-price delivery order with a ceiling value of $3,792.30 and a period of performance through July 2, 2025. This award is not set-aside and was competed openly. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the drug teriparatide 560 mcg/2.24 ml pen in a 2.24 ml quantity. The contract has a firm fixed price of $3,167.44 and a completion date of May 22, 2025. It is not a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $5,330.16, is for the delivery of TERIPARATIDE 600 MCG/2.4ML PEN 2.4ML, a medication used in the treatment of osteoporosis. The contract has a completion date of January 9, 2025 and is a Firm Fixed Price (FFP) contract. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA...
This federal contract award, valued at $5,108.04, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of 4,568,078,779 units of the medication Teriparatide 560MCG/2.24ML Pen 2.24ML. The contract has an ultimate completion date of April 30, 2025 and is a firm fixed-price delivery order with no set-aside designation, indicating open competition. Amerisourcebergen Drug...
This is a $4,573.47 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Teriparatide 560mcg/2.24ml pens, a medication used to treat osteoporosis. The contract has an ultimate completion date of July 3, 2025 and is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with...
  • SPE2DB22D1103
    Indefinite Delivery Contract
  • SPE2DB22D1103-SPE2DB25FTAH4
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of 4,566,077,851 units of the pharmaceutical product Teriparatide 600 mcg/2.4 ml pen (2.4 ml). The contract has a ceiling value of $4,241.15 and a period of performance through October 11, 2024. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, has been awarded multiple federal contracts and indefinite delivery vehicles (IDVs) by the DLA and other agencies to provide a wide range of essential medical commodities, including specialty medications, vaccines, and medical supplies, to support military treatment facilities, veterans' healthcare programs, and other federal healthcare initiatives.

Generated 1/9/25, 9:21 AM